Trademarkia Logo

Canada

C$
ELEVATEBIO
SEARCHED

on 14 May 2024

Last Applicant/ Owned by

ElevateBio, LLC

One Main StreetCambridge, MA 02142

US

Serial Number

1968510 filed on 10th Jun 2019

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

CA

K1P5Y6

ELEVATEBIO

Trademark usage description

advice relating to the organisation and management of business; advisory services for business management; advisory services relating to business mana Read More

Classification Information


Class [035]
Advice relating to the organisation and management of business; Advisory services for business management; Advisory services relating to business management and business operations; business management and advice; Business management assistance; Business management assistance for industrial or commercial companies; Business management consultancy services; Providing advice and information relating to commercial business management


Classification kind code

11

Class [036]
Advice relating to investments. Brokerage services for capital investments. Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations. Business equity research; Business finance procurement services. Capital investment. Capital investment consulting. Capital investment services. Consultancy of capital investment. Debt management consultation. Equity capital investment. Facilitating and arranging for the financing of start up ventures in the field of oncology, pharmaceuticals, and therapeutics. Fiduciary representatives. Financial advice namely financial analysis and business management advice. Financial advice and consultancy services namely, financial analysis and financial analysis consultation services. Financial advisory and consultancy services namely financial analysis consultation services. Financial and investment services, namely, asset and investment acquisition, consultation, advisory and development. Financial consultancy namely, providing advice in the field of medical and scientific research in the field of oncology, cancer and age related diseases. Financial consultancy services in the area of healthcare. Financial consultation namely, financial asset management. Financial consultation in the field of oncology, cancer, age related diseases and therapeutic products for the pharma industry. Financial consulting namely financial forecasting. Financial due diligence, namely auditing of financial statements. Financial investment in the field of oncology and therapeutic products for the pharma industry. Financial loan consultation. Financial portfolio management. Financial research and information services. Financial restructuring services. Financial services in the nature of an investment security. Financial services, namely, raising debt and equity capital for others. Fundraising for others for the purpose of purchasing companies. Funds investment; Incubation services, namely, providing financing to freelancers, start-ups, existing businesses and non-profits. Incubation services, namely, rental of office space to freelancers, start-ups, existing businesses and non-profits. Information, advisory, consultancy and research services relating to finance and investments in the field of oncology, cancer and age related diseases. Investment advisory services in the area of healthcare, oncology, cancer and age related diseases. Investment consultancy namely investment management. Investment consultation namely raising funds for the purpose of oncology. Investment management namely, arranging for funding for medical research and medical product and drug development in the field of oncology, cancer and age related diseases. Investment management in the fields of oncology, cancer, age related diseases and therapeutic products for the pharma industry. Investment management services in the field of acquiring joint ventures. Investment services, namely, asset acquisition, consultation, development and management services in the field of healthcare and oncology. Management of a capital investment fund. Management of private equity funds. Mutual funds and capital investment. Private equity consultant services. Private equity fund investment services. Providing financial information namely financial management. Providing fundraising services for others via a global computer network. Providing investors with financial information in the field of healthcare, oncology, cancer and age related diseases . Providing loans secured by commercial paper. Providing venture capital, development capital, private equity and investment funding. Providing working capital. Providing working capital financing to small businesses and small business owners Provision of financial information in the field of healthcare and oncology Public equity investment management Strategic corporate financial advisory services. Strategic financial advisory services. Venture capital advisory services. Venture capital financing. Venture capital fund management. Venture capital funding services to emerging and start-up companies. Venture capital services, namely, providing financing to emerging and start-up companies.


Classification kind code

11

Class [041]
Education and entertainment


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Business portfolio management and research and development in pharmaceuticals and medical devices. Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy


Classification kind code

11

Mark Details


Serial Number

1968510

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 12
on 20th Nov 2024
Extension of Time
Submitted for opposition 22
on 14th May 2024
Search Recorded
Submitted for opposition 20
on 14th May 2024
Examiner's First Report
Submitted for opposition 67
on 29th Sept 2023
Agent Name Changed
Submitted for opposition 287
on 14th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 48
on 2th Nov 2021
Agent Changed
Submitted for opposition 31
on 13th Jun 2019
Formalized
Submitted for opposition 1
on 11th Jun 2019
Created
Submitted for opposition 30
on 10th Jun 2019
Filed